vs
Side-by-side financial comparison of ENANTA PHARMACEUTICALS INC (ENTA) and Maison Solutions Inc. (MSS). Click either name above to swap in a different company.
Maison Solutions Inc. is the larger business by last-quarter revenue ($27.6M vs $18.6M, roughly 1.5× ENANTA PHARMACEUTICALS INC). Maison Solutions Inc. runs the higher net margin — -18.0% vs -64.1%, a 46.1% gap on every dollar of revenue. On growth, ENANTA PHARMACEUTICALS INC posted the faster year-over-year revenue change (9.8% vs -10.9%). Over the past eight quarters, Maison Solutions Inc.'s revenue compounded faster (42.5% CAGR vs 4.5%).
Enanta Pharmaceuticals Inc is a clinical-stage biotechnology company that develops innovative antiviral therapies for infectious diseases including hepatitis B virus, respiratory syncytial virus (RSV), and SARS-CoV-2. It operates primarily in the U.S. and global markets, partnering with pharmaceutical firms to advance its small molecule drug candidate pipeline for patients with unmet medical needs.
Maison Solutions Inc.MSSEarnings & Financial Report
Maison Solutions Inc. is a specialty home goods retail company that provides a diverse portfolio of stylish, affordably priced furniture, home decor items, and daily household products. Its primary market is the Guangdong-Hong Kong-Macao Greater Bay Area in China, serving mass consumers through both offline physical stores and online e-commerce channels.
ENTA vs MSS — Head-to-Head
Income Statement — Q1 FY2026 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $18.6M | $27.6M |
| Net Profit | $-11.9M | $-5.0M |
| Gross Margin | — | 23.4% |
| Operating Margin | -60.5% | -4.9% |
| Net Margin | -64.1% | -18.0% |
| Revenue YoY | 9.8% | -10.9% |
| Net Profit YoY | 46.4% | -1840.5% |
| EPS (diluted) | $-0.42 | $-0.23 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $18.6M | $27.6M | ||
| Q3 25 | $15.1M | $27.2M | ||
| Q2 25 | $18.3M | $34.4M | ||
| Q1 25 | $14.9M | $32.3M | ||
| Q4 24 | $17.0M | $29.4M | ||
| Q3 24 | $14.6M | $28.2M | ||
| Q2 24 | $18.0M | $16.9M | ||
| Q1 24 | $17.1M | $13.6M |
| Q4 25 | $-11.9M | $-5.0M | ||
| Q3 25 | $-18.7M | $-1.5M | ||
| Q2 25 | $-18.3M | $-287.4K | ||
| Q1 25 | $-22.6M | $1.0M | ||
| Q4 24 | $-22.3M | $-256.0K | ||
| Q3 24 | $-28.8M | $700.9K | ||
| Q2 24 | $-22.7M | $-2.8M | ||
| Q1 24 | $-31.2M | $-549.0K |
| Q4 25 | — | 23.4% | ||
| Q3 25 | — | 24.1% | ||
| Q2 25 | — | 9.5% | ||
| Q1 25 | — | 21.8% | ||
| Q4 24 | — | 26.9% | ||
| Q3 24 | — | 28.9% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 23.4% |
| Q4 25 | -60.5% | -4.9% | ||
| Q3 25 | -121.6% | 0.7% | ||
| Q2 25 | -103.2% | -15.9% | ||
| Q1 25 | -164.3% | 3.7% | ||
| Q4 24 | -138.8% | 3.2% | ||
| Q3 24 | -204.4% | 7.3% | ||
| Q2 24 | -134.6% | -14.4% | ||
| Q1 24 | -192.1% | -2.3% |
| Q4 25 | -64.1% | -18.0% | ||
| Q3 25 | -123.6% | -5.7% | ||
| Q2 25 | -99.7% | -0.8% | ||
| Q1 25 | -151.7% | 3.1% | ||
| Q4 24 | -131.4% | -0.9% | ||
| Q3 24 | -197.3% | 2.5% | ||
| Q2 24 | -126.1% | -16.4% | ||
| Q1 24 | -182.7% | -4.0% |
| Q4 25 | $-0.42 | $-0.23 | ||
| Q3 25 | $-0.88 | $-0.08 | ||
| Q2 25 | $-0.85 | $-0.02 | ||
| Q1 25 | $-1.06 | $0.06 | ||
| Q4 24 | $-1.05 | $-0.01 | ||
| Q3 24 | $-1.36 | $0.04 | ||
| Q2 24 | $-1.07 | $-0.16 | ||
| Q1 24 | $-1.47 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $37.4M | — |
| Total DebtLower is stronger | — | $2.6M |
| Stockholders' EquityBook value | $126.6M | $11.6M |
| Total Assets | $329.5M | $75.4M |
| Debt / EquityLower = less leverage | — | 0.22× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.4M | — | ||
| Q3 25 | $32.3M | $1.1M | ||
| Q2 25 | $44.8M | $775.4K | ||
| Q1 25 | $60.2M | $445.4K | ||
| Q4 24 | $84.3M | $355.7K | ||
| Q3 24 | $37.2M | $588.9K | ||
| Q2 24 | $35.8M | $2.1M | ||
| Q1 24 | $63.5M | $9.4M |
| Q4 25 | — | $2.6M | ||
| Q3 25 | — | $2.6M | ||
| Q2 25 | — | $2.6M | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $2.5M | ||
| Q2 24 | — | $2.6M | ||
| Q1 24 | — | $2.6M |
| Q4 25 | $126.6M | $11.6M | ||
| Q3 25 | $64.7M | $10.1M | ||
| Q2 25 | $79.3M | $11.7M | ||
| Q1 25 | $93.5M | $12.0M | ||
| Q4 24 | $111.8M | $10.9M | ||
| Q3 24 | $128.8M | $11.2M | ||
| Q2 24 | $148.9M | $10.5M | ||
| Q1 24 | $166.1M | $13.3M |
| Q4 25 | $329.5M | $75.4M | ||
| Q3 25 | $280.7M | $73.3M | ||
| Q2 25 | $301.0M | $77.4M | ||
| Q1 25 | $323.0M | $82.7M | ||
| Q4 24 | $348.6M | $82.7M | ||
| Q3 24 | $376.7M | $82.1M | ||
| Q2 24 | $398.8M | $82.4M | ||
| Q1 24 | $413.6M | $44.2M |
| Q4 25 | — | 0.22× | ||
| Q3 25 | — | 0.26× | ||
| Q2 25 | — | 0.22× | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.23× | ||
| Q2 24 | — | 0.24× | ||
| Q1 24 | — | 0.19× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-11.7M | $-1.7M |
| Free Cash FlowOCF − Capex | $-11.8M | — |
| FCF MarginFCF / Revenue | -63.6% | — |
| Capex IntensityCapex / Revenue | 0.8% | — |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-18.5M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-11.7M | $-1.7M | ||
| Q3 25 | $-6.5M | $1.1M | ||
| Q2 25 | $17.5M | $-1.6M | ||
| Q1 25 | $-13.5M | $1.7M | ||
| Q4 24 | $-16.8M | $1.1M | ||
| Q3 24 | $-10.4M | $3.6M | ||
| Q2 24 | $-14.8M | $-2.6M | ||
| Q1 24 | $-28.6M | $-1.4M |
| Q4 25 | $-11.8M | — | ||
| Q3 25 | $-7.9M | — | ||
| Q2 25 | $17.4M | — | ||
| Q1 25 | $-16.0M | — | ||
| Q4 24 | $-25.5M | — | ||
| Q3 24 | $-19.4M | — | ||
| Q2 24 | $-21.3M | — | ||
| Q1 24 | $-30.3M | — |
| Q4 25 | -63.6% | — | ||
| Q3 25 | -52.5% | — | ||
| Q2 25 | 94.7% | — | ||
| Q1 25 | -107.4% | — | ||
| Q4 24 | -150.6% | — | ||
| Q3 24 | -132.5% | — | ||
| Q2 24 | -118.6% | — | ||
| Q1 24 | -177.5% | — |
| Q4 25 | 0.8% | — | ||
| Q3 25 | 9.6% | — | ||
| Q2 25 | 0.8% | — | ||
| Q1 25 | 17.0% | — | ||
| Q4 24 | 51.6% | — | ||
| Q3 24 | 61.3% | — | ||
| Q2 24 | 36.4% | — | ||
| Q1 24 | 9.8% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 1.66× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 5.12× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
ENTA
Segment breakdown not available.
MSS
| Perishables | $14.4M | 52% |
| Nonperishables | $13.2M | 48% |
